Patent ID: 7166285

Claim:
An isolated anti-IL-12 antibody, comprising a heavy chain complementarity determining region 1 (CDR1) of the amino acid sequence set forth in SEQ ID NO:1, a heavy chain complementarity determining region 2 (CDR2) of the amino acid sequence set forth in SEQ ID NO:2, a heavy chain complementarity determining region 3 (CDR3) of the amino acid sequence set forth in SEQ ID NO:3, a light chain complementarity determining region 1 (CDR1) of the amino acid sequence set forth in SEQ ID NO:4, a light chain complementarity determining region 2 (CDR2) of the amino acid sequence set forth in SEQ ID NO:5, and a light chain complementarity determining region 3 (CDR3) of the amino acid sequence set forth in SEQ ID NO:6.